Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone and Metformin ER Combination in Type 2 Diabetes
NCT00754403Phase 4Completed
- Sponsor
- Takeda
- Start
- Jul 2005
- Primary completion
- Oct 2006
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of pioglitazone in type 2 diabetes mellitus (T2DM), sponsored by Takeda. Started Jul 2005; status: completed.
02
Drugs
pioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00754403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00754403.